Rigel’s Tavalisse Hits Pothole In Label Expansion For Hemolytic Anemia

 
• By Joseph Haas
  
Rigel's label-expansion plans for Tavalisse hindered by FORWARD data
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D